Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.
To provide an expert consensus-based update on cardiovascular abnormalities specifically in Masters athletes and their management.
Key Findings:
Masters athletes may have a higher prevalence of cardiovascular abnormalities such as atrial arrhythmias and coronary atherosclerosis, which can complicate management.
Atrial fibrillation prevalence is higher in Masters athletes, particularly among endurance athletes, necessitating tailored monitoring.
Coronary calcification is more common in male Masters athletes compared to less active peers, indicating a need for targeted screening.
Aortic dilatation varies by sport history, with certain sports showing higher prevalence, which may influence management strategies.
Myocardial fibrosis prevalence varies widely and poses diagnostic challenges, requiring careful interpretation in clinical settings.
Interpretation:
Current management strategies for cardiovascular conditions in Masters athletes may not fully apply due to their unique exercise profiles and physiological adaptations, necessitating a tailored approach.
Limitations:
Data on aortic dilatation and myocardial fibrosis are limited and variable, affecting the reliability of conclusions.
Existing studies often have small sample sizes and selection bias, which may skew results.
Lack of athlete-specific evidence to guide treatment complicates management decisions.
Conclusion:
Shared decision-making is crucial in managing cardiovascular health in Masters athletes, considering their unique needs, exercise-related risks, and the variability in individual responses.
